Usefulness of Type D Personality and Kidney Dysfunction as Predictors of Interpatient Variability in Inflammatory Activation in Chronic Heart Failure

American Journal of Cardiology

Volumn 103, Issue 3, 2009, Pages 399-404

  Denollet, Johan ^a   Schiffer, Angélique A ^a,c   Kwaijtaal, Martijn ^a   Hooijkaas, Herbert ^b   Hendriks, Eric H ^c   Widdershoven, Jos W ^c   Kupper, Nina ^a  

^a TILBURG UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c CPRLab   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; SPIRONOLACTONE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE MARKER; EMOTIONAL STRESS; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; INFLAMMATION; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PERSONALITY; PRIORITY JOURNAL; SENESCENCE; TYPE D PERSONALITY;

AGED; CYTOKINES; FEMALE; HEART FAILURE; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; KIDNEY DISEASES; MALE; MIDDLE AGED; PERSONALITY; RECEPTORS, INTERLEUKIN-1; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58749110320     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.09.096     Document Type: Article

References (30)

1. Torre-Amione G., Anker S.D., Bourge R.C., Colucci W.S., Greenberg B.H., Hildebrandt P., Keren A., Motro M., Moyé L.A., Otterstad J.E., et al., Advanced Chronic Heart Failure CLinical Assessment of Immune Modulation Therapy Investigators. Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial. Lancet 371 (2008) 228-236
2. von Haehling S., Jankowska E.A., and Anker S.D. Tumour necrosis factor-alpha and the failing heart--pathophysiology and therapeutic implications. Basic Res Cardiol 99 (2004) 18-28
3. Knight E.L., Rimm E.B., Pai J.K., Rexrode K.M., Cannuscio C.C., Manson J.E., Stampfer M.J., and Curhan G.C. Kidney dysfunction, inflammation, and coronary events: a prospective study. J Am Soc Nephrol 15 (2004) 1897-1903
4. Pecoits-Filho R., Heimburger O., Barany P., Suliman M., Fehrman-Ekholm I., Lindholm B., and Stenvinkel P. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 41 (2003) 1212-1218
5. Cirillo M., Lanti M.P., Menotti A., Laurenzi M., Mancini M., Zanchetti A., and De Santo N.G. Definition of kidney dysfunction as a cardiovascular risk factor: Use of urinary albumin excretion and estimated glomerular filtration rate. Arch Intern Med 168 (2008) 617-624
6. Cook J.R., Dillie K.S., Hakeem A., Bhatti S., and Chang S.M. Effectiveness of anemia and chronic kidney disease as predictors for presence and severity of coronary artery disease in patients undergoing stress myocardial perfusion study. Am J Cardiol 102 (2008) 266-271
7. Ahmed A., Rich M.W., Sanders P.W., Perry G.J., Bakris G.L., Zile M.R., Love T.E., Aban I.B., and Shlipak M.G. Chronic kidney disease associated mortality in diastolic versus systolic heart failure: A propensity matched study. Am J Cardiol 99 (2007) 393-398
8. Denollet J., and Brutsaert D.L. Personality, disease severity, and the risk of long-term cardiac events in patients with a decreased ejection fraction after myocardial infarction. Circulation 97 (1998) 167-173
9. Kop W.J., Weissman N.J., Zhu J., Bonsall R.W., Doyle M., Stretch M.R., Glaes S.B., Krantz D.S., Gottdiener J.S., and Tracy R.P. Effects of acute mental stress and exercise on inflammatory markers in patients with coronary artery disease and healthy controls. Am J Cardiol 101 (2008) 767-773
10. Appels A., Bar F.W., Bar J., Bruggeman C., and de Baets M. Inflammation, depressive symptomatology, and coronary artery disease. Psychosom Med 62 (2000) 601-605
11. Steptoe A., Kunz-Ebrecht S.R., and Owen N. Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women. Psychol Med 33 (2003) 667-674
12. Lespérance F., Frasure-Smith N., Theroux P., and Irwin M. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry 161 (2004) 271-277
13. Conraads V.M., Denollet J., De Clerck L.S., Stevens W.J., Bridts C., and Vrints C.J. Type D personality is associated with increased levels of tumour necrosis factor (TNF)-∝ and TNF-∝ receptors in chronic heart failure. Int J Cardiol 113 (2006) 34-38
14. Denollet J., Conraads V.M., Brutsaert D.L., De Clerck L.S., Stevens W.J., and Vrints C.J. Cytokines and immune activation in systolic heart failure: the role of Type D personality. Brain Behav Immun 17 (2003) 304-309
15. Parissis J.T., Adamopoulos S., Rigas A., Kostakis G., Karatzas D., Venetsanou K., and Kremastinos D.T. Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. Am J Cardiol 94 (2004) 1326-1328
16. Ferketich A.K., Ferguson J.P., and Binkley P.F. Depressive symptoms and inflammation among heart failure patients. Am Heart J 150 (2005) 132-136
17. Redwine L.S., Mills P.J., Hong S., Rutledge T., Reis V., Maisel A., and Irwin M.R. Cardiac-related hospitalization and/or death associated with immune dysregulation and symptoms of depression in heart failure patients. Psychosom Med 69 (2007) 23-29
18. Valgimigli M., Ceconi C., Malagutti P., Merli E., Soukhomovskaia O., Francolini G., Cicchitelli G., Olivares A., Parrinello G., Percoco G., et al. Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: The Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study. Circulation 111 (2005) 863-870
19. Ueland T., Kjekshus J., Froland S.S., Omland T., Squire I.B., Gullestad L., Dickstein K., and Aukrust P. Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients. J Am Coll Cardiol 46 (2005) 2018-2021
20. Deswal A., Petersen N.J., Feldman A.M., Young J.B., White B.G., and Mann D.L. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103 (2001) 2055-2059
21. Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med 67 (2005) 89-97
22. K/DoQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2002) S1-S266
23. Denollet J., Pedersen S.S., Vrints C.J., and Conraads V.M. Usefulness of Type D personality in predicting five-year cardiac events above and beyond concurrent symptoms of stress in patients with coronary heart disease. Am J Cardiol 97 (2006) 970-973
24. Denollet J., and Pedersen S.S. Prognostic value of Type D personality compared with depressive symptoms. Arch Intern Med 168 (2008) 431-432
25. Sher L. Type D personality: The heart, stress, and cortisol. Q J Med 98 (2005) 323-329
26. Molloy G.J., Perkins-Porras L., Strike P.C., and Steptoe A. Type D personality and cortisol in survivors of acute coronary syndrome. Psychosom Med 70 (2008) 863-868
27. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., and de Vries J.E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174 (1991) 1209-1220
28. Kaur K., Sharma A.K., and Singal P.K. Significance of changes in TNF-alpha and IL-10 levels in the progression of heart failure subsequent to myocardial infarction. Am J Physiol Heart Circ Physiol 291 (2006) H106-H113
29. Heeschen C., Dimmeler S., Hamm C.W., Fichtlscherer S., Boersma E., Simoons M.L., Zeiher A.M., and CAPTURE Study Investigators. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107 (2003) 2109-2114
30. Kilic T., Ural D., Ural E., Yumuk Z., Agacdiken A., Sahin T., Kahraman G., Kozdag G., Vural A., and Komsuoglu B. Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome. Heart 92 (2006) 1041-1046